Incyte (INCY), AstraZeneca (AZN) Expand Clinical Trial Collaboration in Early Lung Cancer
October 31, 2017 6:20 AM
Incyte Corporation (Nasdaq: INCY) and MedImmune, AstraZeneca’s (NYSE: AZN) global biologics research and development arm, today announced the expansion of ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
